HIV AIDS News
- U.N. Agency Says AIDS Could Be Ended by 2030
July 14, 2023 — AIDS could be ended as a public health threat by 2030 if political leaders follow the science, invest enough money, and confront inequalities, a report from a United Nations agency says.
- Menopause May Start Earlier for Aging Women With HIV
June 27, 2023 — Studies show that early menopause may occur 5 years earlier in women with HIV than in women without HIV. Here's what to know.
- New HIV Cases Decline, But Prevention Still Falls Short: CDC
May 24, 2023 — The number of people diagnosed with HIV each year in the U.S. continues to decline, according to new CDC data released Tuesday.
- 'Morning After Pill' for STDs Shows Promise in Limiting Disease
May 8, 2023 — The 2023 federally funded study shows that study participants who reported having a sexually transmitted infection in the past year reduced their risk of renewed infection by two-thirds with the protection of the antibiotic.
- HIV Infections Could Spike After Ruling on Affordable Care Act: Experts
March 30, 2023 — Ending coverage of the medication known as PrEP, which was mandated for health insurers under the Affordable Care Act, will result in at least 2,000 new HIV infections within a year, experts said.
- Multiracial Woman ‘Possibly Cured’ of HIV
March 17, 2023 — The middle-aged woman who had HIV but has been in remission after receiving an umbilical cord stem cell transplant more than five years ago for her leukemia is now considered “possibly cured.”
- Man in Germany Cured of HIV With Stem Cells
February 21, 2023 — A 53-year-old man in Germany has been declared cured of HIV.
- Highly Anticipated HIV Vaccine Fails in Large Trial
January 19, 2023 — The only HIV vaccine nearing the completion of testing trials is not effective at preventing HIV, officials announced Wednesday.
- HIV Vaccine Trial Makes Pivotal Leap Toward Making ‘Super Antibodies’
December 2, 2022 — Scientists are one step closer to developing a breakthrough technology that could lead to a vaccine for HIV. The vaccine technology is called germline targeting. Study results show that a vaccine could be designed that can cause the development of made-to-order antibodies in humans.